Comparison of spirometry results in adult patients with cystic fibrosis using different reference values
https://doi.org/10.18093/0869-0189-2025-35-3-340-349
Abstract
Reference values are needed to interpret spirometry results. The ECCS 1993 reference equations are widely used in Russia. A small proportion of medical facilities have implemented the GLI (2012) reference equations. In 2022, ERS/ATS published recommendations for interpreting spirometry results, which recommend assessing the presence of obstructive disorders by a decrease in FEV1/FVC below the 5th percentile (LLN) and the severity of lung function impairment using a z-score.
The aim. To compare spirometry results in adult patients with cystic fibrosis (CF) in Russia using ECCS and GLI reference values.
Methods. Spirometry in 161 CF adults (70 male/91 female, mean age – 26.3 ± 7.6 years) was used for the comparison. The predicted values, % of predicted values (%pred.) and z-score were calculated. The t-tests were used to compare the ECCS and GLI equations.
Results. Obstructive disorders were detected in 127 (79%) CF patients according to ERS/ATS criteria. Predicted GLI and LLN values were higher for FVC and FEV1, but lower for FEF25–75 and FEF75 in both genders. The %pred and z-score for GLI were significantly lower for FVC and FEV1 compared with the %pred and z-score for ECCS: 79.3%pred and –1.75 vs 83.6%pred and –1.31 (p < 0.001), and 58.7%pred and –3.30 vs 61.2%pred and –3.11 (p < 0.001), respectively. A decrease in FVC and FEV1 was detected using the GLI and ECCS equations in 78 (48.4%) and 130 (80.7%) patients and vs 62 (38.5%) and 124 (77.0%) patients, respectively. In addition, the number of patients with severe impairments in both FVC increased when assessed by GLI versus ECCS (mild: 15% vs 11%, moderate: 22% vs 20%, severe: 12% vs 7%, respectively) and FEV1 (mild: 15% vs 14%, moderate: 23% vs 21%, severe: 43% vs 42%, respectively).
Conclusion. In adult patients with cystic fibrosis, the use of GLI equations is associated with increased detection of both lung function impairment and more severe changes in the spirometric parameters FVC and FEV1. The frequency of lowered FVC and FEV1 statistically significantly increases with the use of GLI. Forced spirometry and detection of a decrease in FEV1/FVC are sufficient to diagnose obstructive disorders.
About the Authors
A. V. CherniakRussian Federation
Alexander V. Cherniak - Candidate of Medicine, Head of Laboratory of Functional and Ultrasound Investigations, Federal State Budgetary Institution “Pulmonology Scientific Research Institute” under Federal Medical and Biological Agency of Russian Federation; Doctor of Functional Diagnostics of the Department of functional and ultrasound diagnostics, Moscow State Budgetary Healthcare Institution “Moscow City Hospital named after S.S. Yudin”, Moscow Healthcare Department.
Orekhovyy bul’var 28, build. 10, Moscow, 115682; ul. Akademika Millionshchikova 1, Moscow, 115487; tel.: (495) 395-63-93; Author ID: 687383
Competing Interests:
The authors declare no conflicts of interest
M. Kh. Mustafina
Russian Federation
Malika Kh. Mustafina - Candidate of Medicine, Associate Professor, Department of Cardiology, Functional and Ultrasound Diagnostics, N.V. Sklifosovsky Institute of Clinical Medicine, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First MSMU of the Ministry of Health of the RF (Sechenov University); Senior Researcher, Laboratory of Pathophysiology of Respiration, Federal State Budgetary Institution “Pulmonology Scientific Research Institute” under Federal Medical and Biological Agency of RF.
Orekhovyy bul’var 28, build. 10, Moscow, 115682; ul. Trubetskaya 8, build. 2, Moscow, 119991; tel.: (499) 248-34-77; Author ID: 687382
Competing Interests:
The authors declare no conflicts of interest
S. A. Krasovskiy
Russian Federation
Stanislav A. Krasovskiy - Candidate of Medicine, Senior Researcher, Acting Head of the Cystic Fibrosis Laboratory.
Orekhovyy bul’var 28, build. 10, Moscow, 115682; tel.: (926) 273-76-34; Author ID: 688178
Competing Interests:
The authors declare no conflicts of interest
Zh. K. Naumenko
Russian Federation
Zhanna K. Naumenko - Candidate of Medicine, Senior Researcher, Laboratory of Respiratory Pathophysiology.
Orekhovyy bul’var 28, build. 10, Moscow, 115682; tel.: (495) 651-95-62; Author ID: 393229
Competing Interests:
The authors declare no conflicts of interest
S. Yu. Nistor
Russian Federation
Svetlana Yu. Nistor - Researcher, Laboratory of Respiratory Pathophysiology.
Orekhovyy bul’var 28, build. 10, Moscow, 115682; tel.: (495) 651-95-62
Competing Interests:
The authors declare no conflicts of interest
S. D. Gorbunkov
Russian Federation
Stanislav D. Gorbunkov - Doctor of Medicine, Associate Professor, Chief Physician.
Orekhovyy bul’var 28, build. 10, Moscow, 115682; tel.: (985) 410-67-00; Author ID: 677571
Competing Interests:
The authors declare no conflicts of interest
Ph. Yu. Kopylov
Russian Federation
Philipp Yu. Kopylov - Doctor of Medicine, professor, director, World-Class Research Center “Digital Biodesign and Personalized Healthcare”.
Ul. Trubetskaya 8, build. 2, Moscow, 119991; tel.: (999) 248-34-77; Author ID: 248166
Competing Interests:
The authors declare no conflicts of interest
References
1. Kondratyeva E.I., Voronkova A.Yu., Kashirskaya N.Yu. et al. [Russian registry of patients with cystic fibrosis: lessons and perspectives]. Pul'monologiya. 2023; 33 (2): 171–181. DOI: 10.18093/0869-0189-2023-33-2-171-181 (in Russian).
2. Kameneva M.Yu., Cherniak A.V., Aisanov Z.R. et al. [Spirometry: national guidelines for the testing and interpretation of results Interregional Public Organization “Russian Respiratory Society” All-Russian Public Organization “Russian Association of Specialists in Functional Diagnostics” All-Russian Public Organization “Russian Scientific Medical Society of Therapists”]. Pul'monologiya. 2023; 33 (3): 307–340. DOI: 10.18093/08690189-2023-33-3-307-340 (in Russian).
3. Graham B.L., Steenbruggen I., Miller M.R. et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am. J. Respir. Crit. Care Med. 2019; 200 (8): e70–88. DOI: 10.1164/rccm.201908-1590ST.
4. Miller M.R., Crapo R., Hankinson J. et al. General considerations for lung function testing. Eur. Respir. J. 2005; 26 (1): 153–161. DOI: 10.1183/09031936.05.00034505.
5. Quanjer P.H., Tammeling G.J., Cotes J.E. et al. Lung volumes and forced ventilatory flows. Eur. Respir. J. 1993; 6 (Suppl. 16): 5–40. DOI: 10.1183/09041950.005s1693.
6. Quanjer P.H., Stanojevic S., Cole T.J. et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur. Respir. J. 2012; 40 (6): 1324–1343. DOI: 10.1183/09031936.00080312.
7. Stanojevic S., Kaminsky D.A., Miller M.R. et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur. Respir. J. 2022; 60 (1): 2101499. DOI: 10.1183/13993003.01499-2021.
8. Chushkin M.I., Chernyak A.V., Mustafina M.Kh., Kiryukhina L.D. [The comparison between the European Community for Steel and Coal (ERS/ECCS1993) reference values and the European Respiratory Society reference values for standardization of pulmonary function tests (GLI2012) for spirometry in healthy adults in Russia]. Vestnik TsNIIT. 2024; 8 (4): 64–70. DOI: 10.57014/2587-6678-2024-8-4-64-70 (in Russian).
9. Vukoja M., Bokan A., Vujasinovic G., Kopitovic I. The differences in spirometry predictive equations in classifying presence and degree of lung function impairment: which suit fits the best? Lung. 2018; 196 (1): 87–92. DOI: 10.1007/s00408-017-0065-7.
10. Pellegrino R., Viegi G., Brusasco V. et al. Interpretative strategies for lung function tests. Eur. Respir. J. 2005; 26 (5): 948–968. DOI: 10.1183/09031936.05.00035205.
11. Quanjer P.H., Brazzale D.J., Boros P.W., Pretto J.J. Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry. Eur. Respir. J. 2013; 42 (4): 1046–1054. DOI: 10.1183/09031936.00195512.
12. Quanjer P., Dalhuijsen A., Van Zoramen B. Standardized lung function testing. Report working party. Bull. Eur. Physiopathol. Respir. 1983; 19 (Suppl. 5): 1–95. Available at: https://www.researchgate.net/publication/304373460_Standardized_lung_function_testing_Report_Working_Party_Standardization_of_Lung_Function_Tests_European_Community_for_Coal_and_Steel
13. ECFS Patient Registry. Available at: https://www.ecfs.eu/projects/ecfs-patient-registry/annual-reports [Accessed: 30.03.2025].
Supplementary files
Review
For citations:
Cherniak A.V., Mustafina M.Kh., Krasovskiy S.A., Naumenko Zh.K., Nistor S.Yu., Gorbunkov S.D., Kopylov P.Yu. Comparison of spirometry results in adult patients with cystic fibrosis using different reference values. PULMONOLOGIYA. 2025;35(3):340-349. (In Russ.) https://doi.org/10.18093/0869-0189-2025-35-3-340-349